Brazil's Health Ministry took delivery on Friday of the first batch of insulin produced through the Partnerships for Productive Development (PDP) program. The initiative is part of the National Strategy for the Development of the Health Economic-Industrial Complex and aims to resume manufacturing the drug entirely in the country.
Brazil's National Health Surveillance Agency (Anvisa) has approved the drug Awiqli, produced by the pharmaceutical company Novo Nordisk, to treat adult patients with type 1 and 2 diabetes, Agencia Brasil reported. It is the first weekly insulin shot in the world. There is no date for launching it nationwide.